Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic chloride, (4-fluorophenyl)phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

13020-93-4

Post Buying Request

13020-93-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13020-93-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13020-93-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,0,2 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 13020-93:
(7*1)+(6*3)+(5*0)+(4*2)+(3*0)+(2*9)+(1*3)=54
54 % 10 = 4
So 13020-93-4 is a valid CAS Registry Number.

13020-93-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-fluorophenyl)-N-phenylcarbamoyl chloride

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13020-93-4 SDS

13020-93-4Relevant academic research and scientific papers

FLUORINE RECOGNITION AT THE ACTIVE SITE OF (N-(4-FLUOROPHENYL)-N-PHENYLCARBAMOYL)-α-CHYMOTRYPSIN

Cairi, M.,Gerig, J. T.

, p. 3640 - 3643 (1984)

N-(4-fluorophenyl)-N-phenylcarbamoyl chloride reacts with α-chymotrypsin to give a covalenty modified protein which is devoid of catalytic activity.The fluorophenyl ring of this protein may be found in two magnetically distinct environments; fluorine chem

Metabolism investigation leading to novel drug design 2: Orally active prostacyclin mimetics. Part 5

Takamura, Fujiko,Tanaka, Akira,Takasugi, Hisashi,Taniguchi, Kiyoshi,Nishio, Mie,Seki, Jiro,Hattori, Kouji

, p. 4475 - 4478 (2007/10/03)

A metabolism study of FK788 (2) led to the discovery of new diphenylcarbamoyl derivatives as prostacyclin mimetics without the PG skeleton. We designed and evaluated PGI2 mimetics based on blocking the main metabolic pathway of FK788. The new compound 7c was found to be equipotent to FK788 towards PGI2 agonist activity and metabolically more stable than FK788.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 13020-93-4